LDL Apheresis Treatment
― Prevention of Atherosclerosis, Dyslipidemia, and Diabetic Complications ―
Overview
LDL apheresis is a blood purification therapy that selectively removes low-density lipoprotein cholesterol (LDL-C, “bad cholesterol”) from the bloodstream.
It is particularly effective for patients who do not achieve sufficient improvement with statin or other lipid-lowering medications.
The treatment may help slow the progression of atherosclerosis and diabetic complications such as nephropathy, retinopathy, and arteriosclerosis obliterans (ASO).
Treatment Features
- Removes approximately 60–75% of LDL cholesterol in a single session
- Shown to improve endothelial function and inflammatory markers
- Repeated treatments may provide long-term vascular protection
Device Used in Treatment
Jikei University Hospital uses an adsorption-type blood purification device manufactured by Kaneka Medical Corp., Japan.
This device is designed to remove unwanted substances from the blood while maintaining patient safety.
Indications
Treatment Details
Important Notes
- This treatment is a medical procedure and its effectiveness cannot be guaranteed
- Anticoagulants (such as nafamostat or heparin) are required during the procedure
- The treatment may not be suitable depending on your current medications or health condition
- In rare cases, allergic reactions may occur
- Japanese public health insurance does not cover this treatment (self-funded care)
Cancellation Policy
Appointments must be scheduled in advance.
Please contact us with sufficient time in mind when making your request.
As a general rule, appointments cannot be offered within two weeks.
Please note that a cancellation fee will apply if you cancel after your appointment has been confirmed.